跳至主要内容
临床试验/NCT03474432
NCT03474432终止不适用

SOLEMN Study - Synergy Optical Coherence Tomography in Left Main PCI

Jesse Brown VA Medical Center26 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2018年7月11日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
12
试验地点
26
主要终点
The Stents Analyzed for Strut Coverage in LM Percutaneous Coronary Intervention (PCI)

研究概览

简要总结

BACKGROUD:

Percutaneous coronary intervention (PCI) is increasingly used to treat unprotected left main coronary artery stenosis. Protected LM PCI is considered standard of care in most centers.

OCT allows for precise determination of stent placement, stent expansion and apposition. The pattern of vessel healing can be very precisely studied if immediate post-stent implantation OCT/IVUS data is compared to the 6-month post-PCI interval.

While OCT cannot be optimally used for ostial lesion imaging, IVUS can be used to image ostial lesions/stent placement.

Optimal and consistent vessel healing is particularly important in LM PCI where stent thrombosis is a potential complication with serious adverse outcome.

HYPOTHESIS:

Due to the absorption of the polymer of the Boston Scientific Synergy Stent over time, early strut coverage patterns and timeline may be different than previously observed in DES and BMS stents in LM PCI. Late acquired stent malapposition (LASM) is expected to differ from previous observations with traditional DES/BMS.

Stent coverage in LM PCI will be studied with OCT or IVUS at six and 12 months and compared to OCT or IVUS at the time of stent implantation.

OCT/IVUS data will be analyzed in a core lab (CRF) and correlated with clinical outcomes at 6 and 12 months.

详细描述

The proposed study is a multicenter, observational, prospective, single-arm study of stent strut coverage of patients undergoing LM PCI.

Baseline quantitative coronary analysis (QCA) will be performed at the time of stent implantation.

Stent coverage in LM PCI will be studied with OCT at 3 and 12 months and compared to baseline OCT at the time of stent implantation.(31, 32)

OCT/data will be analyzed in a core lab (CTC CRF) and correlated with clinical outcomes at 3 and 12 months.

Primary Endpoint

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

The Stents Analyzed for Strut Coverage in LM Percutaneous Coronary Intervention (PCI)

时间窗: 3 Months

The stents from 6 participants were analyzed for strut coverage, which is specifically defined as Percentage of Uncovered Stent Struts. The Percentage of Uncovered Stent Struts is the number of struts without distinct overlying tissue, in which the luminal reflection of the strut surface is directly interfacing with the lumen, divided by total number of analyzable struts.

次要结局

  • The Stents Analyzed for Strut Coverage in LM Percutaneous Coronary Intervention (PCI)(12 month)
  • 12-month Persistent Stent Malapposition(12 month)
  • Major Adverse Cardiac Event (MACE)(MACE reported at 12 months)
  • 3-month Persistent Stent Malapposition(3 month)

研究者

申办方类型
Fed
责任方
Principal Investigator
主要研究者

Mladen I. Vidovich

Associate Professor of Medicine, University of Illinois at Chicago and Chief of Cardiology, Jesse Brown VA Medical Center

Jesse Brown VA Medical Center

研究点 (26)

Loading locations...

相似试验